Cooper, Kevin GBhattacharya, SiladityaDaniels, Jane PHorne, Andrew WClark, T JustinSaridogan, ErtanCheed, VershaPirie, DanielleMelyda, MelydaMonahan, MarkRoberts, Tracy ECox, EmmaStubbs, CliveMiddleton, Lee JPRE-EMPT Collaborative Group2024-05-162024-05-162024-05-15Cooper, K G, Bhattacharya, S, Daniels, J P, Horne, A W, Clark, T J, Saridogan, E, Cheed, V, Pirie, D, Melyda, M, Monahan, M, Roberts, T E, Cox, E, Stubbs, C, Middleton, L J & PRE-EMPT Collaborative Group 2024, 'Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain : the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial', BMJ, vol. 385, e079006. https://doi.org/10.1136/bmj-2023-0790060959-8146ORCID: /0000-0002-4588-356X/work/160848278https://hdl.handle.net/2164/2347410551748engHumansFemaleEndometriosis/surgeryContraceptives, Oral, Combined/therapeutic useAdultLevonorgestrel/administration & dosageMedroxyprogesterone Acetate/administration & dosagePelvic Pain/drug therapyProgestins/administration & dosagePain MeasurementSecondary Prevention/methodsTreatment OutcomeYoung AdultIntrauterine Devices, MedicatedR MedicineNational Institute for Health Research (NIHR)11/114/01RLong acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain : the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trialJournal article10.1136/bmj-2023-079006http://www.scopus.com/inward/record.url?scp=85193335482&partnerID=8YFLogxK385